Abstract
Purpose
(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone (PHT) is a phenstatin analog compound. PHT is a known tubulin inhibitor that has potent cytotoxic activity. In the present study, PHT was synthesized and its antitumor activity was determined using in vitro and in vivo experimental models.
Methods
The in vitro cytotoxic activity of the PHT was determined by the MTT assay. The antimitotic and hemolytic effects were determined based on the inhibition of sea urchin embryo development and lysis of mouse erythrocytes, respectively. In vivo antitumor activity was assessed in mice inoculated with sarcoma 180 cells.
Results
In vitro, PHT displayed cytotoxicity in tumor cell lines, showing IC50 values in the nanomolar range. In addition, it inhibited sea urchin embryo development during all phases examined, first and third cleavage and blastula stage. However, PHT did not induce hemolysis using mouse erythrocytes, suggesting that the cytotoxicity of PHT does not involve membrane damage. The in vivo study demonstrated tumor inhibition rates of 30.9 and 48.2% for PHT at doses of 20 and 40 mg/kg, respectively. In addition, PHT was also able to increase the response elicited by 5-fluorouracil (5-FU) from 33.3 to 55.7%. The histopathological analysis of liver, kidney, and spleen showed that they were just moderately affected by PHT treatment. Neither enzymatic activity of transaminases nor urea levels were significantly affected. Hematological analysis showed leukopenia after 5-FU treatment, but this effect was prevented when 5-FU was combined with PHT.
Conclusions
In conclusion, PHT exhibited in vitro and in vivo antitumor effects without substantial toxicity.
Similar content being viewed by others
References
Vernon B, Powell S (2004) Localized delivery system for phenstatin using N-isopropylacrylamide, WO 2004009127
Pettit GR, Grealish MP (2001) Synthesis of hydroxyphenstatin and the prodrugs thereof as anticancer and antimicrobial agents, WO 2001081288
Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M (2008) Naphthylphenstatins as tubulin ligands: synthesis and biological evaluation. Bioorg Med Chem 16:8999–9008
Alvarez R, Alvarez C, Mollinedo F, Sierra BG, Medarde M, Peláez R (2009) Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds. Bioorg Med Chem 17:6422–6431
Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M (2010) Exploring the effect of 2,3,4-trimethoxy-phenyl moiety as a component of indolephenstatins. Eur J Med Chem 45:588–597
Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK (1998) Antineoplastic agents. 379. Synthesis of phenstatin phosphate. J Med Chem 41:1688–1695
Cushman M, Nagarathnam D, Gopal D, He HM, Lin CM, Hamel E (1992) Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. J Med Chem 35:2293–2306
Liou JP, Chang CW, Song JS, Yang YN, Yeh CF, Tseng HY, Lo YK, Chang YL, Chang CM, Hsieh HP (2002) Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents. J Med Chem 45:2556–2562
Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP (2004) Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents. J Med Chem 47:2897–2905
Frank HR, Tarbell DS (1948) Friedel-Crafts reaction on highly methoxylated compounds. J Am Chem Soc 70:1276–1278
Barbosa EG, Bega LAS, Beatriz A, Sarkar T, Hamel E, Amaral MS, Lima DP (2009) A diaryl sulfide, sulfoxide, and sulfone bearing structural similarities to combretastatin A-4. Eur J Med Chem 44:2685–2688
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 16:55–63
Jimenez PC, Fortier SC, Lotufo TMC, Pessoa C, Moraes MEA, Moraes MO, Costa-Lotufo LV (2003) Biological activity in extracts of ascidians (Tunicata, Ascidiacea) from the northeastern Brazilian coast. J Exp Mar Biol Ecol 287:93–101
Bezerra DP, Castro FO, Alves APNN, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM, Costa-Lotufo LV (2006) In vivo growth-inhibition of sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. Braz J Med Biol Res 39:801–807
Wu M, Sun Q, Yang C, Chen D, Ding J, Chen Y, Lin L, Xie Y (2007) Synthesis and activity of Combretastatin A-4 analogues: 1, 2, 3-thiadiazoles as potent antitumor agents. Bioorg Med Chem Lett 17:869–873
Bezerra DP, Pessoa C, Moraes MO, Alencar NM, Mesquita RO, Lima MW, Alves AP, Pessoa OD, Chaves JH, Silveira ER, Costa-Lotufo LV (2008) In vivo growth inhibition of sarcoma 180 by piperlonguminine, an alkaloid amide from the Piper species. J Appl Toxicol 28:599–607
Pessoa C, Silveira ER, Lemos TL, Wetmore LA, Moraes MO, Leyva A (2000) Antiproliferative effects of compounds derived from plants of Northeast Brazil. Phytother Res 14:187–191
Costa-Lotufo LV, Silveira ER, Barros MC, Lima MA, De Moraes ME, De Moraes MO, Pessoa C (2004) Antiproliferative effects of abietane diterpenes from Aegiphila lhotzkyana. Planta Med 70:180–182
Jacobs RS, White S, Wilson L (1981) Selective compounds derived from marine organisms: effects on cell division in fertilized sea urchin eggs. Fed Proc 40:26–29
Alvarez C, Alvarez R, Corchete P, Pérez-Melero C, Peláez R, Medarde M (2007) Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins. Bioorg Med Chem Lett 17:3417–3420
Fusetani N (1987) Marine metabolites which inhibit development of echinoderm embryos. In: Scheur PJ (ed) Biorganic marine chemistry. Springer, Berlin, pp 61–92
Costa-Lotufo LV, Khan MT, Ather A, Wilke DV, Jimenez PC, Pessoa C, de Moraes ME, de Moraes MO (2005) Studies of the anticancer potential of plants used in Bangladeshi folk medicine. J Ethnopharmacol 99:21–30
Bezerra DP, Pessoa C, de Moraes MO, Silveira ER, Lima MA, Elmiro FJ, Costa-Lotufo LV (2005) Antiproliferative effects of two amides, piperine and piplartine, from Piper species. Z Naturforsch C 60:539–543
Kaufman DC, Chabner BA (2001) Clinical strategies for cancer treatment: the role of drugs. In: Chabner BA, Longo DL (eds) Cancer chemotherapy & biotherapy. Lippincott Williams & Wilkins, Philadelphia, pp 1–16
Zamagni C, Martoni A, Cacciari N, Gentile A, Pannuti F (1998) The combination of paclitaxel and carboplatin as first-line chemotherapy in patients with stage III and stage IV ovarian cancer: a phase I-II study. Am J Clin Oncol 21:491–497
Cao X, Cai R, Ju DW, Tao Q, Yu Y, Wang J (1998) Augmentation of hematopoiesis by fibroblast-mediated interleukin-6 gene therapy in mice with chemotherapy. J Interferon Cytokine Res 18:227–233
Saif MW (2009) Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. World J Gastroenterol 15:3855–3864
McGee JOD, Isaacson PA, Wright NA (1992) Oxford textbook of pathology: pathology of systems. Oxford University Press, New York
Scheuer PJ, Lefkowitch JH (2000) Drugs and toxins. In: Scheuer PJ, Lefkowitch JH (eds) Liver biopsy interpretation, 6th edn. W. B. Saunders, London, pp 134–150
Kummar V, Abbas A, Fausto N (2004) Robbins and cotran pathologic basis of disease, 7th edn. W.B., Saunders
Curran RC (1990) Color atlas of histopathology. Oxford University Press, New York
Olsen S, Solez K (1994) Acute tubular necrosis and toxic renal injury. In: Tisher CC, Brenner BM (eds) Renal pathology: with clinical and functional correlations. JB Lippincott, Philadelphia, pp 769–809
Mitchell JA, Gillam EM, Stanley LA, Sim E (1990) Immunotoxic side-effects of drug therapy. Drug Saf 5:168–178
Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Nakajima N (2001) Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 47:11–14
Acknowledgments
We wish to thank CNPq, CAPES, Instituto Claude Bernard, FUNCAP and FINEP for their financial support in the form of grants and fellowship awards. The authors also thank the National Cancer Institute (Bethesda, MD, USA) for the donation of the tumor cell lines used in this study. The authors thank Silvana França dos Santos, Luciana França and Maria de Fátima Teixeira for technical assistance. Dr. A. Leyva helped with English editing of the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Magalhães, H.I.F., Bezerra, D.P., Cavalcanti, B.C. et al. In vitro and in vivo antitumor effects of (4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone. Cancer Chemother Pharmacol 68, 45–52 (2011). https://doi.org/10.1007/s00280-010-1446-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-010-1446-2